Kiromic BioPharma Adds UPMC as Fourth Deltacel-01 Clinical Trial Site - Chronicle-Tribune

Retrieved on: 2024-05-20 18:37:21

Tags for this article:

Click the tags to see associated articles and topics

Kiromic BioPharma Adds UPMC as Fourth Deltacel-01 Clinical Trial Site - Chronicle-Tribune. View article details on hiswai:

Excerpt

HOUSTON--(BUSINESS WIRE)--May 20, 2024--. Kiromic BioPharma, Inc. (OTCQB: KRBP) (“Kiromic” or the “Company”) announces that UPMC in Pittsburgh, ...

Article found on: www.chronicle-tribune.com